Table 2.

Level of MDA and GSH in CuCl-treated RBC model and in G6PD heterozygous women

G6PD activity (%)	MDA (pmol/µg protein)	GSH (µmol/mg protein)
RBC modela,b
10	9.05 (1.31–13.23)	0.95 ± 0.22
20	6.27 (2.87–6.80)	0.97 ± 0.35
30	6.12 (4.84–8.35)	1 ± 0.47
40	14.78 (9.56–23.20)	1.18 ± 0.30
50	16.63 (8.88–32.72)	1.24 ± 0.31
60	9.53 (7.88–29.41)	1.49 ± 0.40
80	14.24 (10.88–26.64)	2.59 ± 0.48
100	15.41 (9.71–34.60)	5.42 ± 0.99
Controlsc
Normal-no H2O2	7.52 ± 2.87	13.76 ± 1.26
Normal-H2O2	15.18 ± 0.32	11.05 ± 0.17
Subjectsc
Subject 1-no H2O2	18.71 ± 3.92	18.6 ± 0.38
Subject 1-H2O2	23.21 ± 0.56	9.11 ± 0.01
Subject 2-no H2O2	12.52 ± 2.72	30.54
Subject 2-H2O2	15.89 ± 0.68	15.51 ± 0.24

^aData of MDA was presented in median (minimum–maximum value)

^bData of GSH was presented in mean ± SD

^cData of MDA and GSH were presented in mean ± SD